With a rapidly growing team of single-cell biologists, genome engineers and deep learning enthusiasts, backed by top-tier TechBio investors, our exciting early stage stealth biotech aims to efficiently engineer sustainable cell state transitions for complex phenotypes and disease. We combine massively scalable high-content single-cell screening and multimodal large language foundation models to identify the best therapies at scale, no matter the ...
With a rapidly growing team of single-cell biologists, genome engineers and deep learning enthusiasts, backed by top-tier TechBio investors. Our exciting early stage biotech, Neptune Bio, aims to efficiently engineer sustainable cell state transitions for complex phenotypes and disease. We combine massively scalable high-content single-cell screening and multimodal large language foundation models to identify the best therapies at scale, no matte...
With a rapidly growing team of single-cell biologists, genome engineers and deep learning enthusiasts, backed by top-tier TechBio investors, Neptune Bio aims to efficiently engineer sustainable cell state transitions for complex phenotypes and disease. We combine massively scalable high-content single-cell screening and multimodal large language foundation models to identify the best therapies at scale, no matter the combinatorial complexity. Fou...
